ClinicalTrials.gg
RecruitingNCT07742748Updated Sep 9, 2026

Carbohydrate-Optimized Nutritional Solution Versus Electrolyte Hydration in Labor

An interventional study of High carbohydrate sports gel and Low carbohydrate hydrogel in Obstetric Labor, sponsored by Institut Investigacio Sanitaria Pere Virgili. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Institut Investigacio Sanitaria Pere Virgili · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Sep 2025, registered Jul 2026).
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This is a pilot randomized, triple-blind clinical trial (pilot RCT) evaluating the preliminary effects of energy supplementation with carbohydrate-rich sports gels compared to a low-sugar sports drink during labor in low-risk pregnant women receiving epidural analgesia.

Labor is associated with substantially increased metabolic demands, while current evidence on intrapartum carbohydrate supplementation remains heterogeneous. This study investigates whether a carbohidrate solution formulation containing improves maternal and neonatal outcomes compared to an other.

A total of 142 term, low-risk pregnant women will be recruited at a single hospital center and randomized to receive either the sports gel or the control beverage. The intervention will begin 60 minutes after epidural analgesia and be repeated every 3 hours until delivery, with a maximum of 4 units administered per participant.

The primary objective is to obtain preliminary estimates of the intervention effects on labor duration and obstetric and neonatal outcomes. Secondary outcomes include cardiotocography patterns, maternal and neonatal glucose levels, postpartum hemorrhage, vomiting episodes, and maternal satisfaction.

This trial was prospectively registered. The study was initially conceived as a pilot randomized controlled trial within an institutional research framework, and registration was completed after participant recruitment had been completed to ensure transparency and adherence to international reporting standards.

The results of this pilot study will inform the design of a future large-scale randomized controlled trial.

Read the detailed description

Background Pregnancy involves an increase in anabolic metabolism, especially during the third trimester due to continuous fetal and placental growth. During active labor, metabolic demands increase further, reaching levels comparable to moderate or intense physical exercise. A 10-hour labor with epidural analgesia may not be adequately supported by clear liquids, saline, or glucose alone; nutritional support should be better adapted to the energy needs of laboring women.

Recent studies have shown mixed results regarding carbohydrate intake during labor, without a consistent effect on labor duration or mode of delivery, although some evidence suggests benefits for maternal comfort and neonatal glycemia

. A 2016 meta-analysis involving 691 women found that oral carbohydrate supplements in small amounts (mean difference of 195 kcal) did not significantly alter labor duration, cesarean rates, or instrumental delivery rates. A large multicenter trial with 3,984 women found no differences in instrumental delivery rates between carbohydrate and fasting groups.

However, a Chinese multicenter trial involving 1,953 primigravid women with epidural analgesia reported reduced maternal hunger and lower neonatal hypoglycemia with carbohydrate supplementation, although higher rates of maternal and neonatal hyperglycemia were observed.

Aspiration Concerns and Modern Practice Historical restrictions on oral intake during labor stem from Mendelson's 1946 description of aspiration risk during general anesthesia. However, modern obstetric anesthesia has evolved considerably, with neuraxial techniques now standard and general anesthesia rarely used for childbirth. Current guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the American Society of Anesthesiologists (ASA) recommend a moderate intake of clear liquids during an uncomplicated labor, while solid foods are generally avoided.The incidence of aspiration in modern obstetric practice is extremely low.

Myometrial Energy Metabolism and Uterine Perfusion From a physiological perspective, the uterus is an extraordinarily active muscle that significantly increases its energy demand during pregnancy and labor.As a myogenic organ, it generates rhythmic contractions without direct nerve stimulation, and its function critically depends on a continuous supply of metabolic substrates. Uterine perfusion illustrates this need: blood flow increases from approximately 45 mL/min in the non-pregnant state to nearly 750 mL/min at the end of gestation.

The causes of delayed labor can be related to the four "P"s: power, passenger, passage, and psyche. Insufficient power can occur when the myometrium is not adequately loaded with glycogen before labor, leading to myometrial dysfunction. Uterine atony, associated with low contractility, causes between 70 and 80% of postpartum hemorrhages, which are estimated to occur in 5-10% of all births.

Glucose as the Primary Myometrial Fuel Glucose is the primary energy source for the myometrium. Glucose concentrations in uterine tissue at the end of pregnancy vastly exceed those in striated muscle. Glycogen stores increase during gestation as a strategic reserve but are rapidly consumed once labor begins. This depletion has been associated with a higher risk of ineffective contractions and uterine dysfunction.

Mitochondria play a central role in this process. Oxytocin increases mitochondrial depolarization, stimulating ATP production and modulating the rhythmicity of contractions.When glucose availability decreases, the myometrium increases its reliance on anaerobic glycolysis, manifesting in an accumulation of lactate and adenosine, which are classic markers of myometrial fatigue. Despite clear physiological evidence highlighting glucose and adequate hydration as critical components for optimal myometrial contractility, restrictive oral intake policies continue to influence modern obstetric care.

To address this clinical discrepancy, this Randomized Clinical Pilot Trial was designed.

Study Design and Methodology This is an experimental, analytical, and triple-blind randomized controlled pilot trial conducted according to CONSORT guidelines. Participants, clinical staff (midwives), and outcome assessors are blinded to group allocation. The study takes place at the Hospital Universitari de Tortosa Verge de la Cinta (HUTVC), Tarragona, Spain.

Group allocation is random and concealed. The hospital pharmacy prepares intervention packages (4 units per participant) and assigns a unique code to each package. The pharmacy maintains a database linking the codes with the intervention type, but does not have access to the identities of the participants. Midwives dispensing the products are unaware of the group allocation. Both interventions were prepared in identical opaque containers with standardized volume, appearance, and labeling.

Interventions and Administration Protocol Intervention Group (High-carbohydrate sports gel): The gel contains a carbohydrate blend designed to promote sustained energy availability.

Control Group (Low-carbohydrate hydrogel): The product contains a lower carbohydrate content. It is modified using a food-grade thickening agent (xanthan gum) to match the viscosity and mouthfeel of the sports gel, ensuring both interventions are indistinguishable.

The first dose is administered 60 minutes after epidural insertion to prevent confounding effects related to the epidural. Subsequent doses are administered every 3 hours during active labor, up to a maximum of 4 doses per participant. Oral water intake is encouraged throughout labor (150-200 mL/hour)

02

Conditions studied

  • Obstetric Labor

Keywords

  • Maternal Outcomes
  • Labor Outcomes
  • Epidural Analgesia
  • oral carbohydrate supplementation
  • Dietary Supplements
  • maternal energy intake
03

In context

Lead sponsor

Institut Investigacio Sanitaria Pere Virgili is the lead sponsor of 39 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnancy classified as Normal Pregnancy, Low-Risk Pregnancy, or Medium-Risk Pregnancy according to the "Protocol de seguiment de l'embaràs a Catalunya" and "Protocol de naixement i acompanyament al naixement de Catalunya".
  • Use of epidural analgesia during labor.
  • Ability to understand Catalan and/or Spanish.
  • Term pregnancy (≥37 weeks gestation).
  • Cephalic presentation.
  • Spontaneous onset of labor, OR induced labor due to prolonged pregnancy or premature rupture of membranes (regardless of duration).
  • Prenatal care at ASSIR Terres de l'Ebre with planned delivery at Hospital Universitari Tortosa Verge de la Cinta.
  • Signed prior to labor.

Exclusion criteria

Exclusion Criteria:

  • Gestational diabetes (including diet and exercise controlled).
  • Multiple gestation.
  • Labor not documented in partograph.
  • not signed prior to labor.
  • Medical indication requiring administration of glucose or glucose-saline intravenous solution during labor (withdrawal criterion).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
147 participants (estimated)

Study arms

  • Experimental
    High carbohydrate sports gel

    Participants receive a carbohydrate solution named High carbohydrate sports gel.The solution contains a mixture of carbohydrates designed to support sustained energy availability. The product is administered 60 minutes after epidural placement and subsequently every 3 hours during active labor, up to a maximum of four administrations. Water intake is encouraged throughout labor.

    Dietary Supplement: High carbohydrate sports gel

  • Active comparator
    Low carbohydrate hydrogel

    Participants receive a low carbohydrate hydrogel. It is modified with xanthan gum (a food-grade thickening agent) to match the viscosity and palatability of the High carbohydrate sports gel. Administration follows the same schedule as the intervention group: first dose 60 minutes after epidural placement and then every 3 hours during active labor, up to a maximum of four administrations.

    Dietary Supplement: Low carbohydrate hydrogel

Interventions

  • Dietary supplementHigh carbohydrate sports gel

    High carbohydrate sports gel (Intervention): The gel provides energy intake with low gastric volume. Low carbohydrate hydrogel (Control Description): A lower-sugar solution. The product is thickened using a food-grade agent to match the viscosity and palatability of the sports gel, ensuring comparability between interventions.

  • Dietary supplementLow carbohydrate hydrogel

    Low carbohydrate hydrogel. Matched in appearance, texture, and administration schedule to the experimental intervention to maintain participant and provider blinding.

06

What researchers measure

Primary outcomes

  1. Duration of Labor

    Time elapsed from epidural catheter insertion until delivery, measured in minutes. Recorded by attending midwife on data collection form.

    Time frame: Timing of epidural analgesia administration to delivery (approximately 1-12 hours).

Secondary outcomes

  1. Postpartum Hemorrhage

    Presence of postpartum hemorrhage defined as blood loss \> 500 mL (yes/no).

    Time frame: Within 24 hours postpartum

  2. Maternal Vomiting Episodes

    Number of vomiting episodes during active labor (count variable).

    Time frame: From first study product administration to delivery

  3. Maternal Blood Glucose

    Capillary blood glucose level measured 60 minutes after intervention administration. Recorded in mg/dL.

    Time frame: 60 minutes after study product administration (repeated if labor exceeds 3 hours)

  4. Maternal Satisfaction

    Maternal satisfaction with labor nutritional support measured using CSTA scale (Client Satisfaction Scale). 5-point ordinal scale: very satisfied, satisfied, neutral, somewhat dissatisfied, very dissatisfied.

    Time frame: Within 24 hours postpartum

  5. Neonatal APGAR Score (1, 5, 10 minutes).

    Standard APGAR score (0-10).

    Time frame: 1, 5 and 10 minutes after birth.

  6. Cardiotocographic Classification

    Fetal heart rate tracing classification according to Spanish clinical practice guidelines for normal birth care. Categorized as: reassuring, non-reassuring, or abnormal. GUIDELINE: Fetal monitoring in labor. NICE guideline \[NG229\] Published:14 December 2022

    Time frame: During active labor until delivery

  7. Neonatal Blood Glucose

    Capillary blood glucose level in the newborn. Recorded in mg/dL.

    Time frame: 60-120 minutes after birth

07

Study locations

1 of 1 sites recruiting
  • HUTVC
    Tortosa, Tarragona 43500, Spain
    Recruiting
08

References and documents

Publications

  • Becker CE, Lorenz W, de Abreu MG, Koch T, Kiss T. Airway management and pulmonary aspiration during surgical interventions in pregnant women in the 2nd/3rd trimester and immediate postpartum - a retrospective study in a tertiary care university hospital. BMC Anesthesiol. 2024 May 3;24(1):166. doi: 10.1186/s12871-024-02551-4. PubMed 38702641 ↗
  • Bruce-Hickman K, Fan K, Plaat F, Sheth S. Decision-making on the labour ward during the COVID-19 pandemic. Int J Obstet Anesth. 2021 Feb;45:150-151. doi: 10.1016/j.ijoa.2020.10.005. Epub 2020 Oct 16. No abstract available. PubMed 33218871 ↗
  • 14.Kaleta T Dr. The Effect of Altered Metabolism on Uterine Contractility [Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy]. University of Liverpool; 2023.

Individual participant data

Plan to share: No — Individual participant data will not be shared. This is a single-center, investigator-initiated pilot randomized controlled trial conducted within a public healthcare setting, and there is currently no formal data sharing infrastructure in place. All data are de-identified and securely stored in accordance with institutional and data protection regulations. Data sharing may be considered in the future following publication of the primary results and development of appropriate data governance procedures.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 25, 2026
First posted
Aug 3, 2026
StartActual
Sep 1, 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07742748
Lead sponsor
Institut Investigacio Sanitaria Pere Virgili
Collaborators
Institut Catala de Salut
Responsible party
Olga Casanova (Investigador principal, Institut Investigacio Sanitaria Pere Virgili) — Principal investigator
First posted
Aug 3, 2026
Start date
Sep 1, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 9, 2026

Study contacts

Olga Casanova Callau, Midwife
Contact
ocasanovac.ebre.ics@gencat.cat
+34977519100 ext. 2120
Jael Lorca Cabrera, PhD
Contact
jlorca.ebre.ics@gencat.cat
+34977519227 ext. 032304
Olga Casanova Callau, Midwife
principal investigator · Institut de Recerca Biomèdica Catalunya Sud (IRBCatSud), Tortosa, Spain; Servei de Paritori, Hospital Universitari de Tortosa Verge de la Cinta, Institut Català de la Salut, Tortosa, Spain.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion